| UniProt ID | CPNE3_HUMAN | |
|---|---|---|
| UniProt AC | O75131 | |
| Protein Name | Copine-3 {ECO:0000305} | |
| Gene Name | CPNE3 {ECO:0000312|HGNC:HGNC:2316} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 537 | |
| Subcellular Localization | Nucleus . Cytoplasm . Cell membrane . Cell junction . Cell junction, focal adhesion . Associates to the membrane in a calcium-dependent manner (PubMed:20010870). Translocates to the cell membrane and the nucleus in a calcium- or growth factor heregul | |
| Protein Description | Calcium-dependent phospholipid-binding protein that plays a role in ERBB2-mediated tumor cell migration in response to growth factor heregulin stimulation. [PubMed: 20010870] | |
| Protein Sequence | MAAQCVTKVALNVSCANLLDKDIGSKSDPLCVLFLNTSGQQWYEVERTERIKNCLNPQFSKTFIIDYYFEVVQKLKFGVYDIDNKTIELSDDDFLGECECTLGQIVSSKKLTRPLVMKTGRPAGKGSITISAEEIKDNRVVLFEMEARKLDNKDLFGKSDPYLEFHKQTSDGNWLMVHRTEVVKNNLNPVWRPFKISLNSLCYGDMDKTIKVECYDYDNDGSHDLIGTFQTTMTKLKEASRSSPVEFECINEKKRQKKKSYKNSGVISVKQCEITVECTFLDYIMGGCQLNFTVGVDFTGSNGDPRSPDSLHYISPNGVNEYLTALWSVGLVIQDYDADKMFPAFGFGAQIPPQWQVSHEFPMNFNPSNPYCNGIQGIVEAYRSCLPQIKLYGPTNFSPIINHVARFAAAATQQQTASQYFVLLIITDGVITDLDETRQAIVNASRLPMSIIIVGVGGADFSAMEFLDGDGGSLRSPLGEVAIRDIVQFVPFRQFQNAPKEALAQCVLAEIPQQVVGYFNTYKLLPPKNPATKQQKQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAAQCVTKV ------CCCHHHHHH | 13.26 | - | |
| 14 | Phosphorylation | TKVALNVSCANLLDK HHHHHCHHHHHHHCC | 13.36 | 30266825 | |
| 21 | Ubiquitination | SCANLLDKDIGSKSD HHHHHHCCCCCCCCC | 51.74 | - | |
| 21 | Acetylation | SCANLLDKDIGSKSD HHHHHHCCCCCCCCC | 51.74 | 26051181 | |
| 25 | Phosphorylation | LLDKDIGSKSDPLCV HHCCCCCCCCCCEEE | 29.35 | 24275569 | |
| 37 | Phosphorylation | LCVLFLNTSGQQWYE EEEEEEECCCCCEEE | 36.06 | 28348404 | |
| 38 | Phosphorylation | CVLFLNTSGQQWYEV EEEEEECCCCCEEEE | 33.27 | 28348404 | |
| 52 | Malonylation | VERTERIKNCLNPQF EECHHHHHHHCCCCC | 48.07 | 26320211 | |
| 52 | Ubiquitination | VERTERIKNCLNPQF EECHHHHHHHCCCCC | 48.07 | - | |
| 54 | S-nitrosylation | RTERIKNCLNPQFSK CHHHHHHHCCCCCCC | 3.10 | 22178444 | |
| 60 | Phosphorylation | NCLNPQFSKTFIIDY HHCCCCCCCEEEHHH | 26.07 | 25849741 | |
| 61 | Ubiquitination | CLNPQFSKTFIIDYY HCCCCCCCEEEHHHH | 49.06 | 21890473 | |
| 76 | Acetylation | FEVVQKLKFGVYDID HHHHHHCCCEEEECC | 47.29 | 26051181 | |
| 76 | 2-Hydroxyisobutyrylation | FEVVQKLKFGVYDID HHHHHHCCCEEEECC | 47.29 | - | |
| 76 | Ubiquitination | FEVVQKLKFGVYDID HHHHHHCCCEEEECC | 47.29 | - | |
| 86 | Phosphorylation | VYDIDNKTIELSDDD EEECCCCEEEECCCC | 26.41 | 28102081 | |
| 90 | Phosphorylation | DNKTIELSDDDFLGE CCCEEEECCCCCCCE | 26.63 | 28102081 | |
| 109 | Acetylation | LGQIVSSKKLTRPLV HHHHHCCCCCCCCEE | 44.27 | 26051181 | |
| 109 | Ubiquitination | LGQIVSSKKLTRPLV HHHHHCCCCCCCCEE | 44.27 | - | |
| 119 | O-linked_Glycosylation | TRPLVMKTGRPAGKG CCCEEECCCCCCCCC | 21.96 | 23301498 | |
| 125 | Ubiquitination | KTGRPAGKGSITISA CCCCCCCCCEEEEEH | 52.14 | 21890473 | |
| 136 | Ubiquitination | TISAEEIKDNRVVLF EEEHHHHHCCEEEEE | 52.83 | 21890473 | |
| 136 | Acetylation | TISAEEIKDNRVVLF EEEHHHHHCCEEEEE | 52.83 | 25953088 | |
| 149 | Ubiquitination | LFEMEARKLDNKDLF EEEEEECCCCCCCCC | 68.21 | - | |
| 153 | Ubiquitination | EARKLDNKDLFGKSD EECCCCCCCCCCCCC | 56.31 | - | |
| 158 | Ubiquitination | DNKDLFGKSDPYLEF CCCCCCCCCCCCCEE | 44.33 | 21890473 | |
| 158 | Malonylation | DNKDLFGKSDPYLEF CCCCCCCCCCCCCEE | 44.33 | 26320211 | |
| 158 | Acetylation | DNKDLFGKSDPYLEF CCCCCCCCCCCCCEE | 44.33 | 23236377 | |
| 159 | Phosphorylation | NKDLFGKSDPYLEFH CCCCCCCCCCCCEEE | 44.17 | 20873877 | |
| 167 | Ubiquitination | DPYLEFHKQTSDGNW CCCCEEEEECCCCCE | 61.67 | 21890473 | |
| 167 | Acetylation | DPYLEFHKQTSDGNW CCCCEEEEECCCCCE | 61.67 | 23954790 | |
| 169 | Phosphorylation | YLEFHKQTSDGNWLM CCEEEEECCCCCEEE | 33.32 | 21406692 | |
| 170 | Phosphorylation | LEFHKQTSDGNWLMV CEEEEECCCCCEEEE | 40.81 | 21406692 | |
| 176 | Sulfoxidation | TSDGNWLMVHRTEVV CCCCCEEEEEEEEEH | 1.48 | 30846556 | |
| 184 | Acetylation | VHRTEVVKNNLNPVW EEEEEEHHCCCCCCC | 45.34 | 23236377 | |
| 184 | Ubiquitination | VHRTEVVKNNLNPVW EEEEEEHHCCCCCCC | 45.34 | 21890473 | |
| 197 | Phosphorylation | VWRPFKISLNSLCYG CCCCEEEECCCEECC | 23.30 | 22617229 | |
| 200 | Phosphorylation | PFKISLNSLCYGDMD CEEEECCCEECCCCC | 25.72 | 25850435 | |
| 203 | Phosphorylation | ISLNSLCYGDMDKTI EECCCEECCCCCCCE | 22.81 | 22817900 | |
| 208 | Ubiquitination | LCYGDMDKTIKVECY EECCCCCCCEEEEEE | 45.58 | - | |
| 208 | 2-Hydroxyisobutyrylation | LCYGDMDKTIKVECY EECCCCCCCEEEEEE | 45.58 | - | |
| 209 | Phosphorylation | CYGDMDKTIKVECYD ECCCCCCCEEEEEEE | 23.05 | 23312004 | |
| 233 | Sulfoxidation | IGTFQTTMTKLKEAS EEEEHHHHHHHHHHH | 3.36 | 28465586 | |
| 235 | Ubiquitination | TFQTTMTKLKEASRS EEHHHHHHHHHHHHC | 46.90 | - | |
| 240 | Phosphorylation | MTKLKEASRSSPVEF HHHHHHHHHCCCCCH | 33.51 | 23401153 | |
| 242 | Phosphorylation | KLKEASRSSPVEFEC HHHHHHHCCCCCHHH | 36.18 | 23927012 | |
| 243 | Phosphorylation | LKEASRSSPVEFECI HHHHHHCCCCCHHHC | 31.67 | 25159151 | |
| 253 | Acetylation | EFECINEKKRQKKKS CHHHCCHHHHHCCHH | 49.09 | 25953088 | |
| 253 | Ubiquitination | EFECINEKKRQKKKS CHHHCCHHHHHCCHH | 49.09 | - | |
| 262 | Ubiquitination | RQKKKSYKNSGVISV HHCCHHCCCCCCEEE | 52.29 | 21890473 | |
| 262 | Malonylation | RQKKKSYKNSGVISV HHCCHHCCCCCCEEE | 52.29 | 32601280 | |
| 262 | Acetylation | RQKKKSYKNSGVISV HHCCHHCCCCCCEEE | 52.29 | 25953088 | |
| 268 | Phosphorylation | YKNSGVISVKQCEIT CCCCCCEEEEEEEEE | 22.36 | 24667141 | |
| 390 | Ubiquitination | RSCLPQIKLYGPTNF HHHCCCCEECCCCCC | 30.34 | - | |
| 390 | Acetylation | RSCLPQIKLYGPTNF HHHCCCCEECCCCCC | 30.34 | 25953088 | |
| 392 | Phosphorylation | CLPQIKLYGPTNFSP HCCCCEECCCCCCHH | 18.96 | 27273156 | |
| 395 | Phosphorylation | QIKLYGPTNFSPIIN CCEECCCCCCHHHHH | 44.53 | 28152594 | |
| 450 | Phosphorylation | NASRLPMSIIIVGVG HHHHCCCEEEEEEEC | 14.54 | 22817900 | |
| 476 | Phosphorylation | GDGGSLRSPLGEVAI CCCCCCCCCCHHHHH | 29.75 | 21815630 | |
| 528 | Ubiquitination | TYKLLPPKNPATKQQ CCCCCCCCCCCCHHH | 73.88 | - | |
| 533 | Ubiquitination | PPKNPATKQQKQ--- CCCCCCCHHHCC--- | 53.49 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CPNE3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CPNE3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CPNE3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SYQ_HUMAN | QARS | physical | 16169070 | |
| VASP_HUMAN | VASP | physical | 22939629 | |
| HNRH1_HUMAN | HNRNPH1 | physical | 26344197 | |
| GRP75_HUMAN | HSPA9 | physical | 26344197 | |
| TRAP1_HUMAN | TRAP1 | physical | 27173435 | |
| SND1_HUMAN | SND1 | physical | 27173435 | |
| IF2P_HUMAN | EIF5B | physical | 27173435 | |
| G6PI_HUMAN | GPI | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |